Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Harvard Business School
McKinsey
US Department of Justice
Deloitte
Mallinckrodt
Express Scripts
QuintilesIMS
Accenture
Moodys

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020180

« Back to Dashboard

NDA 020180 describes PROSCAR, which is a drug marketed by Merck and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the PROSCAR profile page.

The generic ingredient in PROSCAR is finasteride. There are fourteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the finasteride profile page.
Summary for 020180
Tradename:PROSCAR
Applicant:Merck
Ingredient:finasteride
Patents:1
Therapeutic Class:Genitourinary Agents
Hormonal Agents, Suppressant (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Pharmacology for NDA: 020180
Mechanism of Action5-alpha Reductase Inhibitors
Medical Subject Heading (MeSH) Categories for 020180
Suppliers and Packaging for NDA: 020180
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROSCAR finasteride TABLET;ORAL 020180 NDA Merck Sharp & Dohme Corp. 0006-0072 N 0006-0072-31
PROSCAR finasteride TABLET;ORAL 020180 NDA Merck Sharp & Dohme Corp. 0006-0072 N 0006-0072-58

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Jun 19, 1992TE:ABRLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Oct 23, 2018Product Flag?Substance Flag?Delist Request?
Patented Use:TREATING PRECIPITATED ACUTE URINARY RETENTION WITH FINASTERIDE

Expired US Patents for NDA 020180

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Merck PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Merck PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Merck PROSCAR finasteride TABLET;ORAL 020180-001 Jun 19, 1992 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
US Department of Justice
Chinese Patent Office
Julphar
Chubb
Teva
Baxter
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot